Clinical Trial Update: A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating teclistamab in combination with other anticancer therapies for multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Teclistamab (teclistamab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Multiple Myeloma | Phase 1 | Status: ACTIVE_NOT_RECRUITING